K. Blyth (Glasgow (Glasgow), United Kingdom), D. De Fonseka (Sheffield, United Kingdom)
Analysis of circular RNAs expression profile in pleural metastases from lung adenocarcinoma
Q. Xiao (Foshan, China), X. Li (Foshan, China), F. Rong (Foshan, China)
|  |
Utility of LDH-A in the differentiation between lymphocytic pleural effusions of malignantand non-malignant etiology
N. Piskac Živkovic (Zagreb, Croatia), L. Malnar (Zagreb, Croatia), I. Kovacevic (Zagreb, Croatia)
|  |
The smellprint of mesothelioma cells: intrinsic biomarkers for diagnosis and subtyping
E. Janssens (Antwerp, Belgium), E. Marcq (Antwerp, Belgium), L. Vandermeersch (Ghent, Belgium), C. Walgraeve (Ghent, Belgium), J. Van Meerbeeck (Edegem , Belgium), K. Lamote (Antwerp, Belgium)
| |
The role of fibrocyte-like cells in combination treatment of immune checkpoint inhibitor with antiangiogenic agents
. Mitsuhashi (Tokushima, Japan), T. Afroj (Tokushima, Japan), A. Saijo (Tokushima, Japan), K. Otsuka (Tokushima, Japan), H. Yoneda (Tokushima, Japan), K. Koyama (Tokushima, Japan), M. Sugimoto (Tokyo, Japan), O. Kondoh (Tokyo, Japan), H. Nokihara (Tokushima, Japan), Y. Nishioka (Tokushima, Japan)
| |
Effect of primary cilium-associated genes expression on the survival of mesothelioma patients: In silico investigation of TCGA data.
E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
| |
Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy.
M. Bellefroid (Liege, Belgium), C. Sépult (Liege, Belgium), C. Vanwinge (Liege, Belgium), A. Gillard (Liege, Belgium), B. Duysinx (Liege, Belgium), C. Poulet (Liege, Belgium), A. Debit (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium)
| |
Measurement of Natural antibodies (NAbs) against actin, DNA and trinitrophenol in the fluid of pleural effusion patients with various etiologies
I. Sarrigeorgiou (Athens, Greece), O. Kotsiou (Larissa, Greece), E. Rouka (Larissa, Greece), G. Perlepe (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), P. Lymberi (Athens, Greece), S. Zarogiannis (Larissa, Greece)
| |
The UK timed diagnostic lung cancer pathway: a pleural disaster
A. Aujayeb (Newcastle, United Kingdom), K. Jackson (Newcastle, United Kingdom)
| |
MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE.
G. Stella (Pavia (PV), Italy), C. Valizia (Pavia (PV), Italy), L. Saracino (Pavia (PV), Italy), F. Agustoni (Pavia (PV), Italy), E. Pozzi (Pavia (PV), Italy), P. Rinaldi (Pavia (PV), Italy), C. Primiceri (Pavia (PV), Italy), M. Bosio (Pavia (PV), Italy), P. Morbini (Pavia (PV), Italy), C. Bortolotto (Pavia (PV), Italy), A. Corsico (Pavia (PV), Italy)
| |
Influence of psychological distress on symptom burden of patients admitted by malignant pleural effusion
J. Rodriguez Torres (Granada, Spain), M. Granados Santiago (Granada, Spain), A. Heredia Ciuró (Granada, Spain), E. Prados Román (Granada, Spain), A. Rodríguez Rodríguez (Granada, Spain), M. Valenza (Granada, Spain)
| |
In patients with treatment-sensitive cancers, does systemic anti-cancer therapy increase the chance of malignant pleural effusion control?
N. Holling (Bristol, United Kingdom), S. Patole (Bristol, United Kingdom), A. Medford (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), A. Bibby (Bristol, United Kingdom)
| |
Moving forward from Chest Radiography to bedside Ultrasonography for the detection of Pneumothorax. Time to Re-think?
D. Lioumpas (Athens, Greece), T. Michos (Athens, Greece), A. Kleontas (Thessaloniki, Greece), E. Metaxas (Athens, Greece), S. Zaragkas (Athens, Greece), I. Stamatatos (Athens, Greece), N. Fili (Athens, Greece), I. Samiotis (Athens, Greece), K. Bouboulis (Athens, Greece), N. Tzatzadakis (Athens, Greece)
| |
Pleural pointillism and early contrast enhancement as imaging biomarkers of pleural malignancy
S. Tsim (Glasgow (Glasgow), United Kingdom), G. Cowell (Glasgow (Glasgow), United Kingdom), G. Martin (Edinburgh, United Kingdom), L. Alexander (Glasgow, United Kingdom), C. Kelly (Glasgow, United Kingdom), R. Woodward (Glasgow, United Kingdom), J. Foster (Glasgow, United Kingdom), K. Blyth (Glasgow, United Kingdom)
| |
Isolated pleural thickening referred to pulmonologists - challenges and diagnosis
P. Evans (Newport, United Kingdom), E. Shiels (Newport, United Kingdom), A. Ionescu (Newport, United Kingdom)
| |
Computed tomography evidence of lymphangitis associated to malignant pleural effusion: its prevalence and impact on survival
O. Castro Añón (Lugo, Spain), A. Dudina (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), V. George (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), N. Russel (Oxford, United Kingdom), F. Rodríguez-Panadero (Seville, Spain), N. Rahman (Oxford, United Kingdom)
| |
Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy
V. Mismetti (Saint-Etienne, France), G. Karpathiou (Saint-Etienne, France), S. Anevlavis (Alexandroupolis, Greece), O. Tiffet (Saint-Etienne, France), F. Casteillo (Saint-Etienne, France), P. Ntolios (Alexandroupolis, Greece), T. Trouillon (Saint-Etienne, France), M. Peoc`h (Saint-Etienne, France), M. Froudarakis (Alexandroupolis, Greece)
| |
Mesothelioma is associated with ipsilateral thoracic muscle loss
A. Kidd (Glasgow (Glasgow), United Kingdom), A. Winter (Glasgow (Glasgow), United Kingdom), L. Miller (Glasgow (Glasgow), United Kingdom), W. Baird (Glasgow (Glasgow), United Kingdom), C. Dick (Glasgow (Glasgow), United Kingdom), D. Pearce (Edinburgh, United Kingdom), W. Sloan (Glasgow (Glasgow), United Kingdom), G. Cowell (Glasgow (Glasgow), United Kingdom), C. Noble (Glasgow (Glasgow), United Kingdom), A. Smith (Glasgow (Glasgow), United Kingdom), P. Westwood (Glasgow (Glasgow), United Kingdom), T. Hopkins (Glasgow (Glasgow), United Kingdom), N. Williams (Glasgow (Glasgow), United Kingdom), H. Walter (Glasgow (Glasgow), United Kingdom), A. King (Glasgow (Glasgow), United Kingdom), D. Fennell (Glasgow (Glasgow), United Kingdom), K. Blyth (Glasgow (Glasgow), United Kingdom)
| |
Efficacy of Pleurodesis and EGFR TKI in the Treatment of Lung Cancer-mediated Pleural Effusion with EGFR Mutation
K. Li (Chongqing (Chongqing), China), Q. Zhao (Chongqing (Chongqing), China), P. Zhang (Chongqing (Chongqing), China)
| |
Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer
L. Hagmeyer (Solingen, Germany), S. Herkenrath (Solingen, Germany), M. Treml (Solingen, Germany), S. Matthes (Solingen, Germany), K. Richter (Solingen, Germany), K. Hekmat (Cologne, Germany), M. Heldwein (Cologne, Germany), S. Schäfer (Cologne, Germany), R. Büttner (Cologne, Germany), M. Engels (Cologne, Germany), W. Randerath (Solingen, Germany)
| |